Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20762 | 386 | 35.8 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1435 | 7388 | VASCULAR CALCIFICATION//FGF 23//CALCIPHYLAXIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OSTEOPROTEGERIN | Author keyword | 38 | 18% | 50% | 194 |
2 | VASC MED ATHEROTHROMBOSIS | Address | 2 | 50% | 1% | 3 |
3 | INTERDEPARTMENTAL REGENERAT MED | Address | 1 | 50% | 1% | 2 |
4 | NONINVAS VASC UNIT | Address | 1 | 100% | 1% | 2 |
5 | SEVERANCE CEREBRAL CARDIOVASC INTEGRAT | Address | 1 | 100% | 1% | 2 |
6 | SINGLETON MERTEN SYNDROME | Author keyword | 1 | 100% | 1% | 2 |
7 | SECT SPECIALISED ENDOCRINOL | Address | 1 | 40% | 1% | 2 |
8 | MED ENDOCRINOL INTERNAL MED | Address | 1 | 33% | 1% | 2 |
9 | ABNORMAL BONE QUALITY | Author keyword | 1 | 50% | 0% | 1 |
10 | ARETAEIO HOSP | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASMA OSTEOPROTEGERIN | 99 | 80% | 16% | 61 |
2 | SERUM OSTEOPROTEGERIN | 50 | 45% | 22% | 84 |
3 | CIRCULATING OSTEOPROTEGERIN | 7 | 29% | 5% | 21 |
4 | ELEVATED OSTEOPROTEGERIN | 4 | 75% | 1% | 3 |
5 | RANK LIGAND | 4 | 13% | 6% | 25 |
6 | FULL LENGTH OSTEOPROTEGERIN | 3 | 100% | 1% | 3 |
7 | CORONARY ARTERY CALCIFICATIONS | 3 | 60% | 1% | 3 |
8 | SERUM OSTEOPROTEGERIN LEVELS | 3 | 15% | 4% | 16 |
9 | PLASMA OSTEOPROTEGERIN LEVELS | 2 | 67% | 1% | 2 |
10 | HUMAN OSTEOCLASTOGENESIS | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of osteoprotegerin in cardiovascular disease | 2013 | 16 | 128 | 66% |
Osteoprotegerin, vascular calcification and atherosclerosis | 2009 | 98 | 102 | 53% |
Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients | 2013 | 9 | 66 | 67% |
Osteoprotegerin as a marker of atherosclerosis: A systematic update | 2012 | 10 | 33 | 73% |
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications | 2013 | 6 | 53 | 70% |
Osteoprotegerin and kidney disease | 2014 | 2 | 87 | 34% |
Osteoprotegerin in Cardiometabolic Disorders | 2015 | 0 | 107 | 74% |
Osteoprotegerin: Multiple partners for multiple functions | 2013 | 10 | 76 | 24% |
Osteoprotegerin and Diabetes-Associated Pathologies | 2011 | 5 | 148 | 49% |
The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease | 2011 | 6 | 102 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VASC MED ATHEROTHROMBOSIS | 2 | 50% | 0.8% | 3 |
2 | INTERDEPARTMENTAL REGENERAT MED | 1 | 50% | 0.5% | 2 |
3 | NONINVAS VASC UNIT | 1 | 100% | 0.5% | 2 |
4 | SEVERANCE CEREBRAL CARDIOVASC INTEGRAT | 1 | 100% | 0.5% | 2 |
5 | SECT SPECIALISED ENDOCRINOL | 1 | 40% | 0.5% | 2 |
6 | MED ENDOCRINOL INTERNAL MED | 1 | 33% | 0.5% | 2 |
7 | ARETAEIO HOSP | 1 | 50% | 0.3% | 1 |
8 | ASS TRIESTINA 1 | 1 | 50% | 0.3% | 1 |
9 | B BRAUN AVITUM NEPHROL NETWORK | 1 | 50% | 0.3% | 1 |
10 | CARDIOL CORONARY INTENS CARE UNIT | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000296363 | VASCULAR CALCIFICATION//MATRIX GLA PROTEIN//KEUTEL SYNDROME |
2 | 0.0000199139 | RANKL//OSTEOCLAST//OSTEOCLASTOGENESIS |
3 | 0.0000144828 | INTRAMEMBRANOUS BONE GRAFT//ORTHOPEDORTHOPED SURG//AORTIC CALCIFICATION |
4 | 0.0000103564 | FETUIN A//FETUIN//ALPHA 2 HEREMANS SCHMID GLYCOPROTEIN |
5 | 0.0000081671 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |
6 | 0.0000051333 | C PL RATIO//C PL//FATEBENEFRATELLI FDN |
7 | 0.0000049867 | DIABETIC OSTEOPENIA//SPONTANEOUSLY DIABETIC RATS//UNDERCARBOXYLATED OSTEOCALCIN |
8 | 0.0000038661 | MITRAL ANNULAR CALCIFICATION//CALCIFIC AORTIC VALVE DISEASE//VALVULAR INTERSTITIAL CELLS |
9 | 0.0000037845 | OSTEOPONTIN//OSTEOPONTIN OPN//OPN |
10 | 0.0000034867 | CNR AGING BRANCH//CHRONIC OBSTRUCTIVE PULMONARY DISEASE CORTICOSTEROIDS//OPG RANK RANKL |